Hi-Tech Pharmaceuticals Launches Phase 2 PRO IGF-1® Peptide Supplement

NORCROSS, Ga., Sept. 17, 2026 /CourierPR/ -- Hi-Tech Pharmaceuticals, Inc., a leading manufacturer of sports nutrition products, has announced the nationwide launch of its Phase 2 PRO IGF-1® Peptide dietary supplement. This launch marks a significant advancement in the field of dietary supplements, as it offers a natural source of IGF-1 (Insulin-like Growth Factor-1) derived from whey protein.

The company has successfully developed a method to extract 175 micrograms per 100 grams of IGF-1 from whey peptides, a substantial amount that could revolutionize the industry. This achievement is the result of Hi-Tech's commitment to innovation and its expertise in molecular biological techniques. The launch of PRO IGF-1® follows the company's success in Phase 1, during which it distributed its proprietary and patented compounds, including 1-DHEA, 4-DHEA, 19-Nor DHEA, and Senegalia Berlandieri.

IGF-1 is a hormone naturally produced in the liver and plays a crucial role in human growth and development. It is particularly favored by athletes due to its potential to enhance muscle growth, reduce fat, and improve endurance. Unlike growth hormone, which is a precursor to IGF-1, IGF-1 is more stable and can be absorbed in the gastrointestinal tract, making it more bioavailable. Hi-Tech's proprietary Liposomal Delivery (LD) system, known as Cyclosome®, ensures that IGF-1 bypasses digestion, is transported through the bowel wall, and remains bioavailable at the cellular level.

The company's Liposomal Delivery system is a significant breakthrough, as it enhances the effectiveness of IGF-1 by up to 1,500%. This technology is not only applicable to IGF-1 but can also be used for other hormones and nutrients, making Hi-Tech Pharmaceuticals a leader in the development of advanced delivery systems for dietary supplements.

Hi-Tech Pharmaceuticals, founded in 1979, has established itself as a cGMP-certified company with four production facilities and three warehouses, covering over 500,000 square feet. The company's success is attributed to its ability to create, manufacture, and sell high-quality products that are sold by major retailers across the United States.

The launch of PRO IGF-1® is expected to provide a valuable resource for the medical and biotechnology fields, given the many clinical and research applications of IGF-1. The company's innovative approach to extracting and delivering IGF-1 from natural sources could have far-reaching implications for both athletes and individuals seeking to enhance their health and well-being.

In conclusion, the nationwide launch of PRO IGF-1® by Hi-Tech Pharmaceuticals represents a significant milestone in the development of dietary supplements. The company's commitment to innovation and its ability to deliver effective and bioavailable IGF-1 through its Liposomal Delivery system positions it as a leader in the industry.